{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:27:55Z","timestamp":1786544875473,"version":"build-2736575974"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neubiorev.2026.106846","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:39:22Z","timestamp":1783528762000},"page":"106846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Wenting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7187-5910","authenticated-orcid":false,"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.neubiorev.2026.106846_bib1","article-title":"Visceral Adiposity Index (VAI) Levels and Metabolic Risk Across Phenotypes of Polycystic Ovary Syndrome (PCOS)","volume":"61","author":"Akkus","year":"2025","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.neubiorev.2026.106846_bib2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/db16-0755","article-title":"Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight","volume":"66","author":"Anderberg","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.neubiorev.2026.106846_bib3","article-title":"GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review","volume":"35","author":"Aoun","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106846_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14030944","article-title":"Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis","volume":"14","author":"Ayoub","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106846_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0269881113499209","article-title":"Tryptophan: the key to boosting brain serotonin synthesis in depressive illness","volume":"27","author":"Badawy","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114622","article-title":"Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review","volume":"283","author":"Badulescu","year":"2024","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020520","article-title":"Hypothalamic Inflammation as a Potential Pathophysiologic Basis for the Heterogeneity of Clinical, Hormonal, and Metabolic Presentation in PCOS","volume":"13","author":"Barlampa","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106846_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084334","article-title":"The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome","volume":"23","author":"Bednarz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","article-title":"Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies","volume":"32","author":"Behboudi-Gandevani","year":"2016","journal-title":"Gynecol. Endocrinol."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106846_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/09513590.2021.1908254","article-title":"Cortisol and polycystic ovarian syndrome - a systematic search and meta-analysis of case-control studies","volume":"37","author":"Benjamin","year":"2021","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194744","article-title":"GLP-1 physiology and pharmacology along the gut-brain axis","volume":"136","author":"Beutler","year":"2026","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose Tissue Dysfunction in Polycystic Ovary Syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu15020295","article-title":"Emotional Eating and Binge Eating Disorders and Night Eating Syndrome in Polycystic Ovary Syndrome-A Vicious Circle of Disease: A Systematic Review","volume":"15","author":"Burnatowska","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.neubiorev.2026.106846_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70083","article-title":"Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of Semaglutide-Treated and Pair-Fed Rats","volume":"15","author":"Byun","year":"2025","journal-title":"Compr. Physiol."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106846_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091424","article-title":"New Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance","volume":"11","author":"Cai","year":"2022","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.neubiorev.2026.106846_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells11203255","article-title":"Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20\u201329 Years","volume":"11","author":"Carmina","year":"2022","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.neubiorev.2026.106846_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185921","article-title":"Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs","volume":"12","author":"Carmina","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000547055","article-title":"GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity","volume":"19","author":"Celik","year":"2026","journal-title":"Obes. Facts"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","article-title":"Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy","volume":"184","author":"Cesta","year":"2024","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12958-025-01447-3","article-title":"Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight\/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial","volume":"23","author":"Chen","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.neubiorev.2026.106846_bib22","doi-asserted-by":"crossref","first-page":"E10216","DOI":"10.1073\/pnas.1713897114","article-title":"Definition of the hypothalamic GnRH pulse generator in mice","volume":"114","author":"Clarkson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2026.106846_bib23","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.1118355109","article-title":"Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk","volume":"109","author":"Cohen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neubiorev.2026.106846_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.933706","article-title":"Minocycline Reduces Hypothalamic Microglia Activation and Improves Metabolic Dysfunction in High Fat Diet-Induced Obese Mice","volume":"13","author":"Coker","year":"2022","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106846_bib26","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1210\/clinem\/dgae462","article-title":"Increased Prevalence of Binge Eating Disorder and Bulimia Nervosa in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"109","author":"Cooney","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2026.106846_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","article-title":"An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders","volume":"3","author":"De Giorgi","year":"2025","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.neubiorev.2026.106846_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2025.101188","article-title":"Women with polycystic ovary syndrome (PCOS): Likelihood of cooccurring neuropsychiatric conditions and the dual hit hypothesis","volume":"77","author":"Del R\u00edo","year":"2025","journal-title":"Front. Neuroendocrinol."},{"issue":"17","key":"10.1016\/j.neubiorev.2026.106846_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179583","article-title":"Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases","volume":"23","author":"Diz-Chaves","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000548","article-title":"Polycystic ovary syndrome: pathophysiology and therapeutic opportunities","volume":"2","author":"Dong","year":"2023","journal-title":"BMJ Med."},{"key":"10.1016\/j.neubiorev.2026.106846_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neubiorev.2019.10.015","article-title":"Stress-induced plasticity and functioning of ventral tegmental dopamine neurons","volume":"108","author":"Douma","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.fertnstert.2022.03.020","article-title":"Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome","volume":"117","author":"Doycheva","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neubiorev.2026.106846_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2025.101203","article-title":"The overlooked mental health burden of polycystic ovary syndrome: neurobiological insights into PCOS-related depression","volume":"78","author":"Dub\u00e9-Zinatelli","year":"2025","journal-title":"Front. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106846_bib35","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad079","article-title":"Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome","volume":"7","author":"Dumesic","year":"2023","journal-title":"J. Endocr. Soc."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106846_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae162","article-title":"The Subcutaneous Adipose Microenvironment as a Determinant of Body Fat Development in Polycystic Ovary Syndrome","volume":"8","author":"Dumesic","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib37","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2337\/dc11-2250","article-title":"Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity","volume":"35","author":"Dunn","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12902-021-00890-8","article-title":"Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success","volume":"21","author":"Ee","year":"2021","journal-title":"BMC Endocr. Disord."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106846_bib39","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41591-025-03984-1","article-title":"Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes","volume":"31","author":"Gao","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2026.106846_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155280","article-title":"Troxerutin dampened hypothalamic neuroinflammation via microglial IL-22\/IL-22R1\/IRF3 activation in dihydrotestosterone-induced polycystic ovary syndrome rats","volume":"124","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106846_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmet.2023.02.004","article-title":"Estradiol regulates leptin sensitivity to control feeding via hypothalamic Cited1","volume":"35","author":"Gonz\u00e1lez-Garc\u00eda","year":"2023","journal-title":"Cell. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14010027","article-title":"Polycystic Ovary Syndrome and Eating Disorders-A Literature Review","volume":"14","author":"G\u00f3ral","year":"2024","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106846_bib43","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/mp.2014.102","article-title":"Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior","volume":"19","author":"Guo","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106846_bib44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmet.2019.07.008","article-title":"Direct and indirect effects of liraglutide on hypothalamic POMC and NPY\/AgRP neurons - Implications for energy balance and glucose control","volume":"28","author":"He","year":"2019","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib45","article-title":"Circadian rhythm disruption and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"5","author":"Heydari","year":"2025","journal-title":"AJOG Glob. Rep."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106846_bib46","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf125","article-title":"Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits","volume":"166","author":"Hwang","year":"2026","journal-title":"Endocrinology"},{"key":"10.1016\/j.neubiorev.2026.106846_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.acc.2019.11.004","article-title":"Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS","volume":"96","author":"Ilie","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40337-022-00593-y","article-title":"Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial","volume":"10","author":"Jiskoot","year":"2022","journal-title":"J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106846_bib49","article-title":"Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study","volume":"61","author":"Keyif","year":"2025","journal-title":"Med. (Kaunas. )"},{"issue":"19","key":"10.1016\/j.neubiorev.2026.106846_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199702","article-title":"Metabolic and Inflammatory Adipokine Profiles in PCOS: A Focus on Adiposity, Insulin Resistance, and Atherogenic Risk","volume":"26","author":"Koleva-Tyutyundzhieva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27052440","article-title":"Neurotrophin and Adipokine Signatures Associated with Visceral Adiposity-Driven Cardiometabolic and Endocrine Risk in Polycystic Ovary Syndrome","volume":"27","author":"Koleva-Tyutyundzhieva","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75965-2","article-title":"The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy","volume":"14","author":"Kornelius","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106846_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100193","article-title":"Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review","volume":"15","author":"Lalonde-Bester","year":"2024","journal-title":"Adv. Nutr."},{"issue":"5 Pt 2","key":"10.1016\/j.neubiorev.2026.106846_bib54","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.fertnstert.2025.08.023","article-title":"Polycystic ovary syndrome: antim\u00fcllerian hormone and its role in the pathophysiology of the syndrome","volume":"124","author":"Laven","year":"2025","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib55","article-title":"Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials","volume":"15","author":"Lin","year":"2025","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.neubiorev.2026.106846_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cells14221780","article-title":"Hypothalamic Microglia as Dual Hubs Orchestrating Local and Systemic Homeostasis in the Periphery-Central-Periphery Axis","volume":"14","author":"Liu","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib57","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neubiorev.2026.106846_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.150113","article-title":"Tirzepatide reverses hypothalamic inflammation, cellular stress, and neuropeptide imbalance in metabolic-menopausal dysfunction","volume":"1872","author":"Marinho","year":"2026","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106846_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15072786","article-title":"Beyond Glycemic Control: GLP-1RA-Based Therapies and Emerging Targets Beyond the Metabolic Axis","volume":"15","author":"Matuszewski","year":"2026","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib60","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0529","article-title":"Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review","volume":"14","author":"Monney","year":"2025","journal-title":"Endocr. Connect."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106846_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/jne.70028","article-title":"Neuroendocrine mechanisms responsible for elevated gonadotrophin-releasing hormone and luteinising hormone pulses in polycystic ovary syndrome","volume":"37","author":"Moore","year":"2025","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2017.05.002","article-title":"Polycystic ovary syndrome: Understanding the role of the brain","volume":"46","author":"Moore","year":"2017","journal-title":"Front. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106846_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117767119","article-title":"vivo imaging of the GnRH pulse generator reveals a temporal order of neuronal activation and synchronization during each pulse","volume":"119","author":"Moore","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5468\/ogs.24255","article-title":"The impact of GABA and GABAergic pathway in polycystic ovary syndrome: a systematic review","volume":"68","author":"Motafeghi","year":"2025","journal-title":"Obstet. Gynecol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/jpm16020118","article-title":"Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized Psychiatry","volume":"16","author":"Murata","year":"2026","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/JOE-15-0139","article-title":"Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation","volume":"226","author":"Naznin","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/humupd\/dmaf030","article-title":"Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis","author":"Neven","year":"2026","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.neubiorev.2026.106846_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1731179","article-title":"Adipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications","volume":"16","author":"Ni","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.neubiorev.2026.106846_bib69","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clnu.2025.06.011","article-title":"Psychiatric and psychological adverse effects associated with dulaglutide, semaglutide, and liraglutide: A vigibase study","volume":"51","author":"Nishida","year":"2025","journal-title":"Clin. Nutr."},{"issue":"776","key":"10.1016\/j.neubiorev.2026.106846_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk4908","article-title":"Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1\/leptin dual agonist","volume":"16","author":"Polex-Wolf","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib71","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1038\/s41598-024-58064-0","article-title":"Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis","volume":"14","author":"Pratama","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106846_bib72","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i7.108789","article-title":"Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors","volume":"16","author":"Rambaran","year":"2025","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.neubiorev.2026.106846_bib73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13293-016-0059-9","article-title":"Sex and estrogens alter the action of glucagon-like peptide-1 on reward","volume":"7","author":"Richard","year":"2016","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.neubiorev.2026.106846_bib74","first-page":"R582","article-title":"Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus","volume":"277","author":"Rinaman","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"13","key":"10.1016\/j.neubiorev.2026.106846_bib75","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMra2500106","article-title":"GLP-1 Receptor Agonists","volume":"394","author":"Rosen","year":"2026","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106846_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073789","article-title":"Chronic Low Grade Inflammation in Pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106846_bib77","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1097\/MS9.0000000000004189","article-title":"GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review","volume":"87","author":"Saad Alfaiz","year":"2025","journal-title":"Ann. Med. Surg. (Lond. )"},{"key":"10.1016\/j.neubiorev.2026.106846_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106719","article-title":"Allopregnanolone in the pathogenesis of the psychiatric comorbidities of polycystic ovarian syndrome","volume":"250","author":"Sarkisian","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108899","article-title":"Effect of glucagon-like peptide-1 receptor agonists on circulating levels of leptin and resistin: A meta-analysis of randomized controlled trials","volume":"177","author":"Simental-Mend\u00eda","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106846_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14090890","article-title":"Insulin Resistance, Temperament and Personality Traits Are Associated with Anhedonia in a Transdiagnostic Sample","volume":"14","author":"Siwek","year":"2024","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib81","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.japh.2023.10.037","article-title":"The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception","volume":"64","author":"Skelley","year":"2024","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.neubiorev.2026.106846_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2013.00181","article-title":"The central GLP-1: implications for food and drug reward","volume":"7","author":"Skibicka","year":"2013","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib83","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00404-024-07452-y","article-title":"Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study","volume":"309","author":"Sourouni","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib84","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"issue":"21","key":"10.1016\/j.neubiorev.2026.106846_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218211","article-title":"Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence","volume":"21","author":"Steegers-Theunissen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12020-023-03436-1","article-title":"Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome","volume":"82","author":"Stefanaki","year":"2023","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106846_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/nu16071049","article-title":"Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations","volume":"16","author":"Stefanaki","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib88","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41398-023-02424-3","article-title":"Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids","volume":"13","author":"Stiernman","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2026.106846_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1484321","article-title":"GLP-1\/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites","volume":"2020","author":"Sun","year":"2020","journal-title":"Int. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19053089","article-title":"Neuroendocrine Determinants of Polycystic Ovary Syndrome","volume":"19","author":"Szeliga","year":"2022","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib91","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/oby.24254","article-title":"Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program","volume":"33","author":"Tchang","year":"2025","journal-title":"Obes. (Silver Spring)"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106846_bib92","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib93","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106846_bib94","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome\u2020","volume":"38","author":"Teede","year":"2023","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106846_bib95","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27010129","article-title":"Kynurenine Pathway Metabolites as Mediators of Exercise-Induced Mood Enhancement, Fatigue Resistance, and Neuroprotection","volume":"27","author":"Tero-Vescan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106846_bib97","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5694\/mja2.70026","article-title":"Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011-2022: a retrospective open cohort study","volume":"223","author":"Thapaliya","year":"2025","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.neubiorev.2026.106846_bib98","unstructured":"U.S. Food and Drug Administration. FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications. FDA Drug Safety Communication. January 13, 2026. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-communications\/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp."},{"key":"10.1016\/j.neubiorev.2026.106846_bib99","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-physiol-021014-071656","article-title":"Hypothalamic inflammation in the control of metabolic function","volume":"77","author":"Valdearcos","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.07.039","article-title":"GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight","volume":"110","author":"Vogel","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020759","article-title":"A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms","volume":"27","author":"Voros","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib102","first-page":"1216","article-title":"Global Trends in Polycystic Ovary Syndrome Burden, 1990-2021: Insights from the Global Burden of Disease Study","volume":"6","author":"Wang","year":"2025","journal-title":"Women\u2019s. Health Rep. (New. Rochelle)"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106846_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/phar.70135","article-title":"Incretin-Based Therapies for the Treatment of Binge Eating-A Systematic Review","volume":"46","author":"White","year":"2026","journal-title":"Pharmacotherapy"},{"issue":"21","key":"10.1016\/j.neubiorev.2026.106846_bib104","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2026.106846_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1613610","article-title":"Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib106","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/dom.70256","article-title":"Hypothalamic RASA1\/Ras\/AKT\/GnRH axis reprogramming mediates GLP-1RA's central rescue of PCOS HPG dysfunction","volume":"28","author":"Yang","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.neubiorev.2026.106846_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1537360","article-title":"Association between female waist-hip ratio and live birth in patients undergoing in vitro fertilization: a retrospective cohort study","volume":"16","author":"Ye","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106846_bib108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4274\/tjod.galenos.2022.84883","article-title":"Correlation of serum leptin and ghrelin levels with endocrine and reproductive parameters in women with clomiphene citrate resistant polycystic ovary syndrome","volume":"19","author":"Yurci","year":"2022","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"10.1016\/j.neubiorev.2026.106846_bib109","doi-asserted-by":"crossref","DOI":"10.5653\/cerm.2025.08347","article-title":"Relationship between hypothalamic-pituitary-adrenal axis activity and menstrual irregularities in women with polycystic ovary syndrome","author":"Zeynettin","year":"2026","journal-title":"Clin. Exp. Reprod. Med."},{"key":"10.1016\/j.neubiorev.2026.106846_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/obr.70082","article-title":"Role of Reward Dysregulation in the Association Between Depression and Obesity: A Systematical Review","author":"Zhang","year":"2026","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106846_bib111","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/biolre\/ioad032","article-title":"Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue\u2020","volume":"108","author":"Zhang","year":"2023","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib112","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijms.119968","article-title":"Polycystic Ovary Syndrome Revisited: Novel Insights and Updates","volume":"23","author":"Zhao","year":"2026","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106846_bib113","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763426003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:30:04Z","timestamp":1786541404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763426003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":113,"alternative-id":["S0149763426003039"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106846","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106846"}}